About Curateq Biologics Private Limited
Data last updated: 17 February 2026
Curateq Biologics Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 25 April 2020, the company has been in operation for over 6 years.
Registered with ROC Hyderabad under CIN U24110TG2020PTC140190.
Capital: an authorised share capital of ₹115 Cr and a paid-up capital of ₹102.06 Cr. It is led by directors including Madan Mohan Reddy Mettu and Sivakumaran Meenakshisunderam.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.49 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 424 employees as per the latest available data. It operates as a subsidiary of Aurobindo Pharma Ltd. Its group structure includes 1 subsidiary.
The company is associated with 2 brands - Curateq Biologics, Aurobindo Pharma.
For more details, the company can be reached via its website curateqbio.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Curateq Biologics Private Limited
Curateq Biologics Private Limited operates two associated brands: CuraTeQ Biologics and Aurobindo Pharma. These brands represent Curateq Biologics Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Develops high-quality biosimilars for oncology and immunology to enhance patient access worldwide. | curateqbio.com | |
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com |
Competitors & Alternatives of Curateq Biologics Private Limited
Brands and companies operating in the same space as Curateq Biologics Private Limited include Moderna, BeiGene, Strand Therapeutics and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Moderna
|
mRNA-based therapeutics for diseases including cancer and infections are developed. | Cambridge, United States, United States | 2010 |
BeiGene
|
Targeted and immune-oncology drugs for cancer treatment are developed. | Cambridge, United States, United States | 2010 |
Strand Therapeutics
|
mRNA therapeutics platform is provided for multi-functional treatments. | Cambridge, United States, United States | 2017 |
Regeneron Pharmaceuticals
|
Antibodies are developed for treating cancer, eye, and inflammatory diseases. | Tarrytown, United States, United States | 1988 |
Annexon
|
Developer of antibodies to treat complement-mediated neurodegenerative diseases | San Francisco, United States, United States | 2011 |
Ventyx Biosciences
|
Therapeutics for autoimmune diseases are developed by the company. | Encinitas, United States, United States | 2018 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
Incyte
|
Small molecules are developed for cancer and skin disease treatments. | Wilmington, United States, United States | 1991 |
Business Activity of Curateq Biologics Private Limited
Curateq Biologics Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Curateq Biologics Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Curateq Biologics Private Limited
Curateq Biologics Private Limited is audited by G P M & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Curateq Biologics Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Curateq Biologics Private Limited
Curateq Biologics Private Limited is currently managed by 3 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Madan Mohan Reddy Mettu
Also directs:
Mss Packaging Industries Llp, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 5 more
|
Director | 25 Apr 2020 | 6 Years 4 Months | Current |
|
Sivakumaran Meenakshisunderam
Also directs:
Eugia Steriles Private Limited, Tergene Biotech Limited, Auro Peptides Limited and 2 more
|
Director | 25 Apr 2020 | 6 Years 4 Months | Current |
|
Mylandlahalli Rammohan Ashwini
Also directs:
Auro Vaccines Private Limited, Eugia Sez Private Limited, Auro Peptides Limited and 3 more
|
Director | 17 May 2024 | 2 Years 3 Months | Current |
Financials of Curateq Biologics Private Limited FY 2025 filings available
Curateq Biologics Private Limited reported revenue of ₹9.49 Cr (up 3082.00% YoY) for FY 2025.
Ten-year financial statements for Curateq Biologics Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Curateq Biologics Private Limited
Shareholding and ownership data for Curateq Biologics Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Curateq Biologics Private Limited
Curateq Biologics Private Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Curateq Biologics Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Theranym Biologics Private Limited | U24230TG2022PTC166946 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings Curateq Biologics Private Limited
Curateq Biologics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Curateq Biologics Private Limited
Curateq Biologics Private Limited has a workforce of 424 employees as of Aug 06, 2024.
Employee and EPFO history for Curateq Biologics Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Curateq Biologics Private Limited
GST registrations and filing compliance for Curateq Biologics Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Curateq Biologics Private Limited
Credit ratings, litigation, and regulatory alerts for Curateq Biologics Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curateq Biologics Private Limited
MSME payment history for Curateq Biologics Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curateq Biologics Private Limited
Corporate group structure for Curateq Biologics Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curateq Biologics Private Limited
MCA filings and documents for Curateq Biologics Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Curateq Biologics Private Limited
Frequently Asked Questions about Curateq Biologics Private Limited
Curateq Biologics Private Limited is an active private limited company in the life sciences sector based in Hyderabad, Telangana, India. It was incorporated on 25 April 2020 (6+ years old) and is registered under CIN U24110TG2020PTC140190. The company has 424 employees.
Curateq Biologics Private Limited reported revenue of ₹9.49 Cr for FY 2025 (up 3082.00% YoY).
The current directors of Curateq Biologics Private Limited are:
- Madan Mohan Reddy Mettu - Director
- Sivakumaran Meenakshisunderam - Director
- Mylandlahalli Rammohan Ashwini - Director
The primary industry of Curateq Biologics Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Curateq Biologics Private Limited can be reached at the registered office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032, or through the website curateqbio.com.
The authorised capital is ₹115 Cr, and the paid-up capital is ₹102.06 Cr.